natgillin/translations-raw huggingface dataset:
- in adult patients (particularly overweight patients) inadequately controlled by diet and exercise for whom metformin is inappropriate because of contraindications or intolerance as dual oral therapy in combination with - metformin, in adult patients (particularly overweight patients) with insufficient glycaemic control despite maximal tolerated dose of monotherapy with metformin - a sulphonylurea, only in adult patients who show intolerance to metformin or for whom metformin is contraindicated, with insufficient glycaemic control despite maximal tolerated dose of monotherapy with a sulphonylurea as triple oral therapy in combination with
- u odraslih bolesnika (osobito bolesnika s prekomjernom tjelesnom težinom) u kojih se kontrola ne postiže dijetom i tjelovježbom i u kojih metformin nije prikladan zbog kontraindikacija ili nepodnošenja kao dvojna peroralna terapija u kombinaciji s
- Pioglitazone Teva 15 mg tablets are white to off white, round, convex with the number ‘15' on one side and ‘TEVA' on the other side.
- Pioglitazon Teva 15 mg tablete su bijele do gotovo bijele boje, okrugle, konveksne, s oznakom ‘15' na jednoj strani i ‘TEVA' na drugoj.
However, certain medicines are especially likely to affect the amount of sugar in your blood: - gemfibrozil (used to lower cholesterol) - rifampicin (used to treat tuberculosis and other infections) Tell your doctor or pharmacist if you are taking any of these.
- rifampicin (primjenjuje se za liječenje tuberkuloze i drugih infekcija) Obavijestite svog liječnika ili ljekarnika ako uzimate te lijekove.
Respiratory, thoracic and mediastinal disorders dyspnoea common
Poremećaji dišnog sustava, prsišta i sredoprsja dispneja
Pioglitazone Teva 45 mg tablets
Pioglitazon Teva 45 mg tablete
Blurred vision due to swelling (or fluid) at the back of the eye (frequency cannot be estimated from the available data) has also been reported in patients taking pioglitazone.
U bolesnika koji uzimaju pioglitazon zabilježen je i zamagljen vid zbog oticanja (ili tekućine) stražnje strane oka (učestalost se ne može procijeniti iz dostupnih podataka).
Each Pioglitazone Teva 30 mg tablet contains 30 mg of pioglitazone (as hydrochloride).
Jedna tableta lijeka Pioglitazon Teva od 30 mg sadrži 30 mg pioglitazona (u obliku pioglitazonklorida).
Pioglitazone Teva 30 mg tablets
Pioglitazon Teva 30 mg tablete
Ear and labyrinth disorders vertigo uncommon
Poremećaji uha i labirinta vrtoglavica manje često
Pioglitazone Teva 45 mg tablets Pioglitazone
Pioglitazon Teva 45 mg tablete pioglitazon
This is to check that your liver is working normally.
Trebate provjeravati tjelesnu težinu u redovitim vremenskim razmacima.
Each Pioglitazone Teva 45 mg tablet contains 45 mg of pioglitazone (as hydrochloride).
Jedna tableta lijeka Pioglitazon Teva od 45 mg sadrži 45 mg pioglitazona (u obliku pioglitazonklorida).
No dose adjustment is necessary in patients with impaired renal function (creatinine clearance > 4 ml/min) (see section 5.2).
> 4 ml/min) (vidjeti dio 5.2).
Each tablet contains 45 mg pioglitazone (as hydrochloride).
Jedna tableta sadrži 45 mg pioglitazona (u obliku pioglitazonklorida).
Pioglitazone Teva 30 mg tablets Pioglitazone
Pioglitazon Teva 30 mg tablete pioglitazon
Pioglitazone Teva 15 mg tablets
Pioglitazon Teva 15 mg tablete
Each tablet contains 30 mg pioglitazone (as hydrochloride).
Jedna tableta sadrži 30 mg pioglitazona (u obliku pioglitazonklorida).
The other side effects that have been experienced by some patients when pioglitazone is taken with other antidiabetic medicines are:
Druge nuspojave koje su neki bolesnici osjetili kod uzimanja pioglitazona s drugim antidijabetičkim lijekovima su: vrlo često (mogu se javiti u više od 1 od 10 osoba)
If you experience any of these, talk to your doctor as soon as possible.
Ako primijetite ovu nuspojavu, čim prije razgovarajte s Vašim liječnikom.
- diabetic ketoacidosis - current bladder cancer or a history of bladder cancer - uninvestigated macroscopic haematuria
- oštećenjem funkcije jetre - dijabetičkom ketoacidozom - postojećim ili preboljenim karcinomom mokraćnog mjehura
Co-administration of pioglitazone with rifampicin (an inducer of cytochrome P450 2C8) is reported to result in a 54% decrease in AUC of pioglitazone.
Zabilježeno je da istodobna primjena pioglitazona s rifampicinom (induktor citokroma P450 2C8) rezultira smanjenjem
Metabolism and nutrition disorders hypo-glycaemia uncommon very common
Poremećaji metabolizma i prehrane hipoglikemija manje često vrlo često pojačan apetit manje često
The tablets are white to off-white, round, convex and debossed with the number ‘45' on one side and ‘TEVA' on the other side.
Tablete su bijele do gotovo bijele boje, okrugle, konveksne i imaju oznaku ‘45' s jedne strane i ‘TEVA' s druge strane.
Each Pioglitazone Teva 15 mg tablet contains 15 mg of pioglitazone (as hydrochloride).
Jedna tableta lijeka Pioglitazon Teva od 15 mg sadrži 15 mg pioglitazona (u obliku pioglitazonklorida).
Each tablet contains 15 mg pioglitazone (as hydrochloride).
Jedna tableta sadrži 15 mg pioglitazona (u obliku pioglitazonklorida).
Pioglitazone Teva 15 mg tablets Pioglitazone
Pioglitazon Teva 15 mg tablete pioglitazon
The tablets are white to off-white, round, convex and debossed with the number ‘30' on one side and ‘TEVA' on the other side.
Tablete su bijele do gotovo bijele boje, okrugle, konveksne i imaju oznaku ‘30' s jedne strane i ‘TEVA' s druge strane.
In most clinical trials, reduced total plasma triglycerides and free fatty acids, and increased HDLcholesterol levels were observed as compared to placebo, with small, but not clinically significant increases in LDL-cholesterol levels.
HDL-kolesterola u usporedbi s placebom, uz mala ali ne i klinički značajna povišenja razine LDL
Marketing Authorisation Holder:
Nositelj odobrenja za stavljanje gotovog lijeka u promet:
nausea or vomiting).
- osjećaj vrtnje (vrtoglavica)
If you experience this side effect, talk to your doctor as soon as possible.
Ako razvijete ovu nuspojavu, čim prije razgovarajte s Vašim liječnikom.
very common (may affect more than 1 in 10 people) - decreased blood sugar (hypoglycaemia)
- utrnulost manje često (mogu se javiti do 1 od 100 osoba) - upala sinusa (sinusitis)
It is not known whether pioglitazone is secreted in human milk.
Nije poznato izlučuje li se pioglitazon u majčino mlijeko u ljudi pa se stoga pioglitazon ne smije primjenjivati u dojilja.
The observed excess risk of fractures for women in this dataset on pioglitazone is therefore 0.8 fractures per 100 patient years of use.
Opaženo povećanje rizika od prijeloma u žena u ovom sklopu podataka o pioglitazonu stoga iznosi
Mon. Tue.
- znojenje - umor
The tablets are white to off-white, round, convex and debossed with the number ‘15' on one side and ‘TEVA' on the other side.
Tablete su bijele do gotovo bijele boje, okrugle, konveksne i imaju oznaku ‘15' s jedne strane i ‘TEVA' s druge strane.
Rare cases of elevated liver enzymes and hepatocellular dysfunction have occurred in post-marketing experience.
Nakon stavljanja lijeka u promet bilo je rijetkih slučajeva povišenih jetrenih enzima i poremećaja funkcije jetre.
България Тева Фармасютикълс България ЕООД
UAB “Sicor Biotech” Eesti filiaal
Neoplasms benign, malignant and unspecified (including cysts and polyps)
Dobroćudne, zloćudne i nespecificirane novotvorine
Tel: +421 2 57 26 79 11
TEVA Pharmaceuticals Slovakia s.r.o. Tel: +421 2 57 26 79 11
Co-administration of pioglitazone with gemfibrozil (an inhibitor of cytochrome P450 2C8) is reported to result in a 3-fold increase in AUC of pioglitazone.
Zabilježeno je da istodobna primjena pioglitazona s gemfibrozilom (inhibitor citokroma P450 2C8)
common (may affect up to 1 in 10 people) - respiratory infection - abnormal vision - weight gain - numbness uncommon (may affect up to 1 in 100 people) - inflammation of the sinuses (sinusitis) - difficulty sleeping (insomnia)
Ostale nuspojave koje su osjetili neki bolesnici koji uzimaju pioglitazon su: često (mogu se javiti do 1 od 10 osoba) - infekcija dišnih putova - abnormalni vid
Pliva Hrvatska d.o.o.
artralgija križobolja
Patients should be observed for signs and symptoms of heart failure, weight gain and oedema when pioglitazone is used in combination with insulin.
Kad se pioglitazon primjenjuje u kombinaciji s inzulinom, bolesnike treba nadzirati zbog znakova i simptoma zatajenja srca, povećanja tjelesne težine i pojave edema.
Renal and urinary disorders haematuria common glycosuria uncommon proteinuria uncommon
Poremećaji bubrega i mokraćnog sustava hematurija glikozurija manje često proteinurija manje često
It is especially important to mention these:
Osobito je važno da spomenete sljedeće:
Your doctor will test for these changes.
Vaš liječnik će obaviti provjere u vezi tih promjena.
Your child's doctor will decide this.
To će odlučiti liječnik Vašeg djeteta.
Date of first authorisation: 22 August 2016
Datum prvog odobrenja: 22 kolovoz 2016
During the second and third trimesters of pregnancy
Tijekom drugog i trećeg tromjesečja trudnoće
15 to less than 35
15 do manje od 35
These could be symptoms of a serious heart problem.
To mogu biti simpotmi ozbiljnog srčanog problema.
Such changes may in part be linked to the disease control and life style.
Te promjene mogu biti djelomično povezane s kontrolom bolesti i stilom života.
The clinical relevance of these non-clinical data is unknown.
Klinička važnost ovih nekliničkih podataka nije poznata.
No deaths were reported.
Nije prijavljen niti jedan smrtni slučaj.
An alternate reliable method of contraception is recommended.
Preporučuje se neka druga pouzdana metoda kontracepcije.
In some patients additional factor VIII was given.
Nekim se bolesnicima dodatno davao faktor VIII.
Confidence interval.
Interval pouzdanosti.
Difference estimate e
Procjena razlike e
Do not open the capsules.
Ne otvarajte kapsule.
Wait and take the next dose at its regular time.
Pričekajte i uzmite sljedeću dozu u uobičajeno vrijeme.
If genotyping is not feasible, full monitoring of safety and efficacy should be performed.
Ako se ne može provesti genotipizacija, potrebno je provoditi cjelovit nadzor sigurnosti i djelotvornosti.
Didanosine (with food)
Didanozin (s hranom)
Week 48
48. tjedan
Without tenofovir
Bez tenofovira
The same recommendations for drug drug interactions would apply except:
Vrijede iste preporuke za interakcije između lijekova, osim sljedećega:
Week 96
96. tjedan
Some patients required hospitalization for additional management and some had complications.
Neki bolesnici su radi daljnjeg liječenja trebali hospitalizaciju, a neki su imali komplikacije.
You may continue to develop infections or other illnesses linked to HIV infection.
I dalje se u Vas mogu razviti infekcije ili druge bolesti povezane s HIV-infekcijom.
Cmin is concentration 24 hours post-dose.
Cmin je koncentracija 24 sata nakon doze.
If it is almost time for your next dose, do not take the missed dose.
Ako je uskoro vrijeme za sljedeću dozu, nemojte uzeti propuštenu dozu.
• absence of prior virologic failure
• izostanak prethodnog virološkog neuspjeha
It is important to note that at time of the 96-week analysis, 48 % of patients overall remained on study.
Važno je primijetiti da je u vrijeme analize podataka iz 96. tjedna u ispitivanju ostalo ukupno 48% bolesnika.
• Changes in the way your heart beats (heart rhythm change) may occasionally happen.
• Promjenje u načinu na koje Vaše srce kuca (promjena srčanog ritma) mogu se povremeno dogoditi.
• hypersensitivity (allergic reaction)
• preosjetljivost (alergijska reakcija)
In the prepartum period, additional monitoring should be considered.
U pretpartalnom razdoblju, potrebno je razmotriti mogućnost dodatnog nadzora.
• undetectable viral load during the last 6 months under current regimen
• nemjerljivo virusno opterećenje tijekom posljednjih 6 mjeseci liječenja trenutnim režimom
Single doses up to 1,200 mg have been taken by healthy volunteers without symptomatic untoward effects.
Zdravi dobrovoljci uzimali su jednokratne doze do 1200 mg bez simptomatskih neželjenih učinaka.
100 mg at least 35
100 mg najmanje 35
• if you have hepatitis B or C
• ako imate hepatitis B ili C
This side effect is usually not dangerous in adults and infants older than 3 months of age; but it might be a symptom of a serious problem.
Ta nuspojava obično nije opasna u odraslih i dojenčadi starijoj od 3 mjeseca ali može biti i simptom ozbiljnog problema.
Analyses of data through 96 weeks of treatment demonstrated durability of antiviral activity (Table 5).
Analize podataka prikupljenih tijekom 96 tjedana liječenja pokazala je trajnost antivirusnog djelovanja (tablica 5).
Caution should be exercised.
Potreban je oprez.
There were no clinically important pharmacokinetic differences based on age or gender.
Nije bilo klinički značajnih farmakokinetičkih razlika na temelju dobi ili spola.
There was no evidence of pathologic jaundice and six of 40 infants in this study received phototherapy for a maximum of 4 days.
Nije bilo znakova patološke žutice, a šestero od 40 dojenčadi u ovom ispitivanju primilo je fototerapiju u trajanju od najviše 4 dana.
Therefore if the combination is unavoidable, the following recommendations are made according to the CYP2C19 status:
Stoga se, ako je ova kombinacija neizbježna, donose sljedeće preporuke sukladno statusu CYP2C19:
For children (6 to less than 18 years of age), your child's doctor will decide the right dose based on your child's weight.
Za djecu (u dobi od 6 do manje od 18 godina), liječnik Vašeg djeteta odlučit će koja je doza ispravna na temelju tjelesne težine Vašeg djeteta.
If you miss a dose, take the missed dose as soon as possible with food and then take your next scheduled dose at its regular time.
Ako propustite uzeti dozu, uzmite propuštenu dozu čim prije s hranom, a potom uzmite sljedeću dozu prema rasporedu u uobičajeno vrijeme.
Responders on LPV/RTV who completed treatment before Week 96 are excluded from Week 96 analysis.
Bolesnici s odgovorom na LPV/RTV koji su završili liječenje prije 96. tjedna isključeni su iz analize podataka 96. tjedna.
Paediatric patients (less than 3 months of age)
Pedijatrijski bolesnici (mlađi od 3 mjeseca)
• if you are allergic to atazanavir or any of the other ingredients of this medicine (listed in section 6)
• ako ste alergični na atazanavir ili neki drugi sastojak ovog lijeka (naveden u dijelu 6)
Food effect
Utjecaj hrane
Typically, such reactions have been observed within the first few weeks or months of initiation of CART.
Tipično su takve reakcije opažene tijekom prvih nekoliko tjedana ili mjeseci nakon uvođenja terapije CART.
Ritonavir capsules, tablets or oral solution.
Ritonavir kapsule, tablete ili oralna otopina.
15 to less than 35 At least 35 * Ritonavir capsules, tablets or oral solution may be used.
15 do manje od 35 najmanje 35 * Mogu se uzimati ritonavir kapsule, tablete ili oralna otopina.
It is believed that these symptoms are due to an improvement in the body's immune response, enabling the body to fight infections that may have been present with no obvious symptoms.
Vjeruje se da ti simptomi nastaju zbog poboljšanog imunološkog odgovora tijela, koji tijelu omogućuje da se bori protiv infekcija koje su možda prisutne bez očitih simptoma.
Caution is warranted and therapeutic concentration monitoring is recommended when available.
Traži se oprez i preporučuje se praćenje terapijske koncentracije, kad je dostupno.
For lipids, there is in some cases evidence for a treatment effect, while for weight gain there is no strong evidence relating this to any particular treatment.
Za lipide, u nekim slučajevima postoji dokaz o učinku liječenja, dok za debljanje nema čvrstog dokaza povezanosti s bilo kojim posebnim liječenjem.
The best results in managing these events come from early diagnosis and immediate interruption of any suspect medicines.
Najbolji rezultati u liječenju ovih promjena postižu se ranom dijagnozom i hitrim prekidom primjene svakog sumnjivog lijeka.
Mylan S.A.S., 117 Allee des Parcs, Saint-Priest, 69800, France
Mylan S.A.S., 117 Allee des Parcs, Saint-Priest, 69800, Francuska
More frequent therapeutic concentration monitoring of these medicinal products is recommended until plasma levels have been stabilised.
Preporučuje se češće praćenje terapijskih koncentracija ovih lijekova dok se ne stabiliziraju razine u plazmi.
Patients should be advised of the signs and symptoms and monitored closely for skin reactions.
Bolesnike treba upozoriti na znakove i simptome i pažljivo ih nadzirati zbog kožnih reakcija.
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Ako ste trudni ili dojite, mislite da biste mogli biti trudni ili planirate imati dijete, obratite se svom liječniku za savjet prije nego uzmete ovaj lijek.
Safety
Sigurnost
A causal relationship has been suggested, although the mechanism of action has not been elucidated.
Smatra se da postoji uzročno-posljedična veza, iako mehanizam djelovanja nije razjašnjen.
It is normally used in combination with other anti-HIV medicines.
Obično se uzima u kombinaciji s drugim lijekovima protiv HIV-a.
The requirements for submission of periodic safety update reports for this medicinal product are set out in the list of Union reference dates (EURD list) provided for under Article 107c(7) of Directive 2001/83/EC and any subsequent updates published on the European medicines web-portal.
Zahtjevi za podnošenje periodičkih izvješća o neškodljivosti za ovaj lijek definirani su u referentnom popisu datuma EU (EURD popis) predviđenom člankom 107.c stavkom 7.Direktive 2001/83/EZ i svim sljedećim ažuriranim verzijama objavljenima na europskom internetskom portalu za lijekove.
Withdrawal of ritonavir only under restrictive conditions
Prekid primjene ritonavira samo pod restriktivnim uvjetima
There is a trend toward a higher clearance in younger children when normalised for body weight.
Vidi se trend prema većem klirensu u mlađe djece, kad se normalizira prema tjelesnoj težini.
Clinical results
Klinički rezultati
A dose reduction of buprenorphine may be considered
Može se razmotriti sniženje doze buprenorfina.
Per protocol analysis: Excluding non-completers and patients with major protocol deviations.
Analiza prema protokolu: isključujući one koji nisu dovršili ispitivanje i bolesnike s velikim odstupanjima od protokola.
Animal studies do not indicate reproductive toxicity (see section 5.3).
Ispitivanja na životinjama ne ukazuju na reproduktivnu toksičnost (vidjeti dio 5.3).
Buprenorphine, once daily, stable maintenance dose
Buprenorfin, jedanput na dan, stabilna doza održavanja
- Keep this leaflet.
• Sačuvajte ovu uputu.
If you have liver problems, including hepatitis B or C infection, you may experience a worsening of your liver problems.
Ako imate problema s jetrom, uključujući infekciju hepatitisom B ili C, možete primijetiti pogoršanje Vaših problema s jetrom.
Frequency is defined using the following convention: very common (≥ 1/10), common (≥ 1/100 to < 1/10), uncommon (≥ 1/1,000 to < 1/100), rare (≥ 1/10,000 to < 1/1,000), very rare (< 1/10,000).
Učestalost se definira na sljedeći način: vrlo često (≥ 1/10), često (≥ 1/100 i < 1/10), manje često (≥ 1/1000 i < 1/100), rijetko (≥ 1/10 000 i < 1/1000), vrlo rijetko (< 1/10 000).
• angioedema (severe swelling of the skin and other tissues most often the lips or the eyes)
• angioedem (teško oticanje kože i drugih tkiva, najčešće usana i očiju)
A study of the pharmacokinetics of atazanavir was performed in 59 healthy male and female subjects (29 young, 30 elderly).
Ispitivanje farmakokinetike atazanavira provedeno je u 59 zdravih muškaraca i žena (29 mladih, 30 starijih).
Dosage adjustment for midazolam should be considered, especially if more than a single dose of midazolam is administered.
Potrebno je razmotriti prilagodbu doze midazolama, osobito ako se primjenjuje više od jednokratne doze midazolama.
In this instance, close clinical monitoring is warranted (see Interaction with other Medicinal Products below).
U tom je slučaju obavezan strogi klinički nadzor (vidjeti Interakcije s drugim lijekovima, niže).
If your skin or the white part of your eyes turns yellow, talk to your doctor immediately.
Ako Vaša koža ili bjeloočnica postanu žuti odmah se obratite liječniku.
Table 2: Interactions between atazanavir and other medicinal products
Tablica 2: Interakcije između atazanavira i drugih lijekova
This way, you can be sure your medicine is fully effective and you reduce the risk of the virus developing resistance to the treatment.
Na taj ćete način biti sigurni da je lijek potpuno učinkovit i smanjiti rizik od razvoja otpornosti virusa na liječenje.
Moreover, in case of withdrawal of glucocorticoids, progressive dose reduction may have to be performed over a longer period.
Nadalje, u slučaju prestanka primjene glukokortikoida, može se provesti progresivno smanjenje doze tijekom duljeg razdoblja.
In more than half of the reported cases, treatment with protease inhibitors was continued or reintroduced if treatment had been discontinued.
U više od polovice zabilježenih slučajeva nastavilo se s liječenjem inhibitorima proteaze ili se liječenje ponovno uvelo ako je bilo prekinuto.
There is a risk of loss of therapeutic effect and development of resistance (see section 4.3).
Postoji rizik od gubitka terapijskog učinka i razvoja rezistencije (vidjeti dio 4.3).
• insomnia (difficulty sleeping)
• nesanica (poteškoće sa spavanjem)
You can still pass on HIV when taking this medicine, although the risk is lowered by effective antiretroviral therapy.
HIV možete prenijeti čak i dok uzimate ovaj lijek, iako je tada rizik od prijenosa manji zbog učinkovite antiretrovirusne terapije.
In the majority of cases, jaundice was reported within a few days to a few months after the initiation of treatment (see section 4.4).
U većine slučajeva, žutica je bila zabilježena unutar nekoliko dana do nekoliko mjeseci nakon početka liječenja (vidjeti dio 4.4).
• if you are taking an oral contraceptive ("the Pill") with Atazanavir Mylan to prevent pregnancy, be sure to take it exactly as instructed by your doctor and not miss any doses.
• ako uzimate oralnu kontracepciju ("pilule") s lijekom Atazanavir Mylan za sprečavanje trudnoće, pazite da je uzimate točno prema uputama liječnika i da ne propustite niti jednu dozu
Any inflammatory symptoms should be evaluated and treatment instituted when necessary.
Svaki upalni simptom treba procijeniti i liječiti u slučaju potrebe.
Precautions to prevent transmission should be taken in accordance with national guidelines.
Treba poduzeti mjere opreza za sprječavanje prijenosa bolesti u skladu s nacionalnim smjernicama.
Thirty-two percent of patients in the study had a viral strain with fewer than two NRTI substitutions.
Trideset dva posto bolesnika u ovom ispitivanju imalo je virusni soj s manje od dvije supstitucije za rezistenciju na NRTI.
Immune reactivation syndrome
Sindrom imunološke reaktivacije
It is recommended that the International Normalised Ratio (INR) be monitored carefully during treatment with atazanavir, especially when commencing therapy.
Preporučuje se pažljivo pratiti međunarodni normalizirani omjer (INR) tijekom liječenja atazanavirom, osobito na početku terapije.
Administration of activated charcoal may also be used to aid removal of unabsorbed drug.
Primjena aktivnog ugljena također se može koristiti kao pomoć u uklanjanju neapsorbiranog lijeka.
When treating HIV infection, it is not always easy to identify what side effects are caused by atazanavir, by the other medicines you are taking, or by the HIV infection itself.
Kod liječenja HIV-infekcije, nije uvijek lako utvrditi koje su nuspojave izazvane atazanavirom, koje drugim lijekovima koje uzimate, a koje samom HIV-infekcijom.
Although not studied, similar results are expected with other proton pump inhibitors.
Iako se to nije ispitivalo, slični se rezultati očekuju s drugim inhibitorima protonske pumpe.
It is one of a group called protease inhibitors.
Pripada skupini lijekova koji se zovu inhibitori proteaze.